ArticleBMC pulmonary medicine2026
TGF-β2 and KL-6 as potential biomarkers for hard metal lung disease.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundsHard metal lung disease (HMLD) is an occupational disease caused by exposure to hard metal (HM) dust. We explored TGF-β1, TGF-β2 and KL-6 as potential biomarkers for HMLD by examining their levels in bronchoalveolar lavage fluid (BALF) and serum.
methodsForty-eight female Sprague-Dawley rats were divided into hard metal (HM) and normal control (NC) groups. The HM group was exposed to tungsten carbide-cobalt dust (WC-Co) dust via intratracheal instillation. Cytokine levels in BALF and serum were measured at 4-, 8-, and 12-weeks. Lung changes were assessed by micro-CT and histopathology.
resultsAt 4-, 8-, and 12-weeks, the micro-CT showed ground glass opacities, diffuse ground-glass nodules, and scattered ground glass opacities in both lungs of HM group rats, while the pathological tissue found inflammatory cell infiltration, a large number of multinucleated giant cells, and inflammatory cell infiltration, respectively. TGF-β2 levels in BALF were significantly higher in the HM group at 8 and 12 weeks, while serum TGF-β2 levels were lower. KL-6 levels in BALF were elevated in the HM group at 12 weeks, but serum KL-6 levels were lower at 8 weeks.
conclusionsTGF-β2 and KL-6 levels in BALF and serum demonstrate dynamic changes associated with HMLD progression and may serve as potential biomarkers for diagnosis and monitoring. Further studies are needed to explore the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.